跳至主要内容
临床试验/IRCT20221022056269N1
IRCT20221022056269N1招募中1 期

Comparison of the efficacy of ketamine-midazolam combination with midazolam alone in the treatment of status epilepticus resistant to first- and second-line treatments in patients with refractory status epilepticus

Shiraz University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Patients with refractory status epilepticus
  • Age between 18-50 years ohd

排除标准

  • The pregnant patients
  • The patients with sepsis
  • Post hypoxic patients
  • The patients with multi organ damage
  • The patients with high blood pressure and increased intracranial pressure

研究者

相似试验

effect of midazolam- ketamine combination in... | 临床试验